Frank Gansauge

Summary

Country: Germany

Publications

  1. ncbi Treatment of pancreatic cancer: challenge of the facts
    Hans G Beger
    World J Surg 27:1075-84. 2003
  2. ncbi The clinical efficacy of adjuvant systemic chemotherapy with gemcitabine and NSC-631570 in advanced pancreatic cancer
    Frank Gansauge
    Center for Oncological, Endocrinological and Minimal access Surgery, University of Ulm, Silcherstr 36, 89231 Neu Ulm, Germany
    Hepatogastroenterology 54:917-20. 2007
  3. ncbi NSC-631570 (Ukrain) in the palliative treatment of pancreatic cancer. Results of a phase II trial
    Frank Gansauge
    Department of General Surgery, University of Ulm, Germany
    Langenbecks Arch Surg 386:570-4. 2002
  4. ncbi Systemic immune dysfunction in pancreatic cancer patients
    Bertram Poch
    Center for Oncological, Endocrinological and Minimal access Surgery, Silcherstr 36, 89231 Neu Ulm, Germany
    Langenbecks Arch Surg 392:353-8. 2007
  5. ncbi Effect of early and late antibiotic treatment in experimental acute pancreatitis in rats
    Michael Schwarz
    Department of General Surgery, University of Ulm, Ulm, Germany
    Langenbecks Arch Surg 392:365-70. 2007
  6. ncbi Cyclooxygenase-2 is overexpressed in chronic pancreatitis
    Wolfgang Schlosser
    Department of General Surgery, University of Ulm, Ulm, Germany
    Pancreas 25:26-30. 2002
  7. ncbi Down-regulation of BRCA1 in chronic pancreatitis and sporadic pancreatic adenocarcinoma
    Carmela Beger
    Department of Pediatric Hematology, Hannover Medical School, Hannover, Germany
    Clin Cancer Res 10:3780-7. 2004
  8. ncbi Influence of PMN leukocyte-mediated pancreatic damage on the systemic immune response in severe acute pancreatitis in rats
    Uwe A Wittel
    Department of General, Visceral, and Transplantation Surgery, University of Freiburg, 79106 Freiburg, Germany
    Dig Dis Sci 49:1348-57. 2004
  9. ncbi Duodenum-preserving total pancreatic head resection for cystic neoplastic lesions in the head of the pancreas
    Hans G Beger
    c o Universitätsklinikum Ulm, Steinhovelstrasse 9, D 89075 Ulm, Germany
    J Hepatobiliary Pancreat Surg 15:149-56. 2008

Collaborators

Detail Information

Publications9

  1. ncbi Treatment of pancreatic cancer: challenge of the facts
    Hans G Beger
    World J Surg 27:1075-84. 2003
    ..Therefore, after oncological resection of pancreatic cancer each patient should be offered adjuvant treatment. A neoadjuvant treatment protocol for pancreatic cancer, however, has not been established...
  2. ncbi The clinical efficacy of adjuvant systemic chemotherapy with gemcitabine and NSC-631570 in advanced pancreatic cancer
    Frank Gansauge
    Center for Oncological, Endocrinological and Minimal access Surgery, University of Ulm, Silcherstr 36, 89231 Neu Ulm, Germany
    Hepatogastroenterology 54:917-20. 2007
    ..The aim of this study was to determine the effectiveness of the combined treatment with Gemcitabine and NSC-631570 in the adjuvant treatment of resected advanced pancreatic cancer...
  3. ncbi NSC-631570 (Ukrain) in the palliative treatment of pancreatic cancer. Results of a phase II trial
    Frank Gansauge
    Department of General Surgery, University of Ulm, Germany
    Langenbecks Arch Surg 386:570-4. 2002
    ..01). CONCLUSION: We could show that in unresectable advanced pancreatic cancer, NSC-631570 alone and in combination with gemcitabine nearly doubled the median survival times in patients suffering from advanced pancreatic cancer...
  4. ncbi Systemic immune dysfunction in pancreatic cancer patients
    Bertram Poch
    Center for Oncological, Endocrinological and Minimal access Surgery, Silcherstr 36, 89231 Neu Ulm, Germany
    Langenbecks Arch Surg 392:353-8. 2007
    ..We investigated the immune status in 32 pancreatic cancer patients (PC) in comparison with healthy controls (HC)...
  5. ncbi Effect of early and late antibiotic treatment in experimental acute pancreatitis in rats
    Michael Schwarz
    Department of General Surgery, University of Ulm, Ulm, Germany
    Langenbecks Arch Surg 392:365-70. 2007
    ..The effect of two antibiotic regimens for early and late treatment was investigated in the taurocholate model of necrotizing pancreatitis in the rat...
  6. ncbi Cyclooxygenase-2 is overexpressed in chronic pancreatitis
    Wolfgang Schlosser
    Department of General Surgery, University of Ulm, Ulm, Germany
    Pancreas 25:26-30. 2002
    ..The constitutively expressed cyclooxygenase-1 (COX-1) appears to regulate many normal physiologic functions in several cell types, whereas the inducible cyclooxygenase-2 (COX-2) enzyme mediates the inflammatory response...
  7. ncbi Down-regulation of BRCA1 in chronic pancreatitis and sporadic pancreatic adenocarcinoma
    Carmela Beger
    Department of Pediatric Hematology, Hannover Medical School, Hannover, Germany
    Clin Cancer Res 10:3780-7. 2004
    ..However, as demonstrated for breast and ovarian cancer, inactivation of BRCA in sporadic diseases is based on alteration in gene expression or functional alteration...
  8. ncbi Influence of PMN leukocyte-mediated pancreatic damage on the systemic immune response in severe acute pancreatitis in rats
    Uwe A Wittel
    Department of General, Visceral, and Transplantation Surgery, University of Freiburg, 79106 Freiburg, Germany
    Dig Dis Sci 49:1348-57. 2004
    ..Only the treatment with anti-ICAM-1 mAb affected these changes, indicating that immunological changes in necrotizing pancreatitis are only in part affected by early PMN leukocyte-mediated pancreatic damage...
  9. ncbi Duodenum-preserving total pancreatic head resection for cystic neoplastic lesions in the head of the pancreas
    Hans G Beger
    c o Universitätsklinikum Ulm, Steinhovelstrasse 9, D 89075 Ulm, Germany
    J Hepatobiliary Pancreat Surg 15:149-56. 2008
    ..We report the following data from 15 patients treated surgically for cystic neoplastic lesions of the pancreas head...